Literature DB >> 12684217

Expression of somatostatin, cortistatin, and somatostatin receptors in human monocytes, macrophages, and dendritic cells.

Virgil A S H Dalm1, P Martin van Hagen, Peter M van Koetsveld, Sam Achilefu, Adriaan B Houtsmuller, David H J Pols, Aart-Jan van der Lely, Steven W J Lamberts, Leo J Hofland.   

Abstract

Increasing evidence suggests that neuropeptides play a role in the regulatory mechanisms between the neuroendocrine and immune systems. A differential expression of the five known somatostatin (SS) receptors (sst1-5) has been demonstrated in human immune cells and tissues. However, little is known concerning regulation and expression of sst1-5 and the peptide SS. Therefore, we investigated the expression and the time-dependent regulation of sst1-5, SS, and cortistatin (CST), a novel SS-like peptide, in human monocytes (MO), monocyte-derived macrophages (MP), and dendritic cells (DC) in the basal and lipopolysaccharide (LPS)-activated state. MO, MP, and DC selectively expressed sst2 mRNA. SS mRNA was not detectable, whereas all samples expressed CST mRNA. Expression levels of sst2 and CST mRNA showed marked differences and were in the rank order of MP>>DC>>>MO. LPS stimulation did not induce expression of SS or sst1,3,4,5. However, sst2 mRNA expression was upregulated significantly by stimulation with LPS. CST mRNA was upregulated as well. During differentiation of MO in MP or DC, time-dependent, significantly increasing sst2 and CST mRNA levels were found. By confocal microscopy, the presence of sst2 receptors was demonstrated on MP, but not on DC. This study demonstrates for the first time a selective and inducible expression of the recently discovered CST, as well as sst2, in human monocyte-derived cells, suggesting a role for a CST-sst2 system rather than a SS-sst2 system in these immune cell types.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12684217     DOI: 10.1152/ajpendo.00048.2003

Source DB:  PubMed          Journal:  Am J Physiol Endocrinol Metab        ISSN: 0193-1849            Impact factor:   4.310


  52 in total

1.  Evolutionary conservation of neuropeptide expression in the thymus of different species.

Authors:  Alberto B Silva; Danielle Aw; Donald B Palmer
Journal:  Immunology       Date:  2006-05       Impact factor: 7.397

2.  Cubilin and megalin in radiation-induced renal injury with labelled somatostatin analogues: are we just dealing with the kidney?

Authors:  R Moncayo
Journal:  Eur J Nucl Med Mol Imaging       Date:  2005-10       Impact factor: 9.236

Review 3.  Frontiers in positron emission tomography imaging of the vulnerable atherosclerotic plaque.

Authors:  Mark G MacAskill; David E Newby; Adriana A S Tavares
Journal:  Cardiovasc Res       Date:  2019-12-01       Impact factor: 10.787

4.  Cortistatin, an antiinflammatory peptide with therapeutic action in inflammatory bowel disease.

Authors:  Elena Gonzalez-Rey; Nieves Varela; Amir F Sheibanie; Alejo Chorny; Doina Ganea; Mario Delgado
Journal:  Proc Natl Acad Sci U S A       Date:  2006-03-07       Impact factor: 11.205

Review 5.  Somatostatin receptor scintigraphy in thoracic diseases.

Authors:  P Ameri; F Gatto; M Arvigo; G Villa; E Resmini; F Minuto; G Murialdo; D Ferone
Journal:  J Endocrinol Invest       Date:  2007-11       Impact factor: 4.256

Review 6.  International Union of Basic and Clinical Pharmacology. CV. Somatostatin Receptors: Structure, Function, Ligands, and New Nomenclature.

Authors:  Thomas Günther; Giovanni Tulipano; Pascal Dournaud; Corinne Bousquet; Zsolt Csaba; Hans-Jürgen Kreienkamp; Amelie Lupp; Márta Korbonits; Justo P Castaño; Hans-Jürgen Wester; Michael Culler; Shlomo Melmed; Stefan Schulz
Journal:  Pharmacol Rev       Date:  2018-10       Impact factor: 25.468

Review 7.  Control of myeloid cell trafficking in resolution.

Authors:  Lucy V Norling; Mauro Perretti
Journal:  J Innate Immun       Date:  2013-04-30       Impact factor: 7.349

8.  Assessment of vulnerable atherosclerotic and fibrotic plaques in coronary arteries using (68)Ga-DOTATATE PET/CT.

Authors:  Alireza Mojtahedi; Abass Alavi; Sanjay Thamake; Reza Amerinia; David Ranganathan; Izabela Tworowska; Ebrahim S Delpassand
Journal:  Am J Nucl Med Mol Imaging       Date:  2014-12-15

Review 9.  Current and novel radiopharmaceuticals for imaging cardiovascular inflammation.

Authors:  Gyu S Heo; Deborah Sultan; Yongjian Liu
Journal:  Q J Nucl Med Mol Imaging       Date:  2020-02-18       Impact factor: 2.346

10.  68Ga-DOTATOC PET/CT and somatostatin receptor (sst1-sst5) expression in normal human tissue: correlation of sst2 mRNA and SUVmax.

Authors:  Christian Boy; Till A Heusner; Thorsten D Poeppel; Anja Redmann-Bischofs; Nicole Unger; Walter Jentzen; Wolfgang Brandau; Klaus Mann; Gerald Antoch; Andreas Bockisch; Stephan Petersenn
Journal:  Eur J Nucl Med Mol Imaging       Date:  2011-03-03       Impact factor: 9.236

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.